A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Targeted cell delivery is useful in a variety of biomedical applications. The goal of this protocol is to use superparamagnetic iron oxide nanoparticles (SPION) to label cells and thereby enable magnetic cell targeting approaches for a high degree of control over cell delivery and localization.
Targeted delivery of cells and therapeutic agents would benefit a wide range of biomedical applications by concentrating the therapeutic effect at the target site while minimizing deleterious effects to off-target sites. Magnetic cell targeting is an efficient, safe, and straightforward delivery technique. Superparamagnetic iron oxide nanoparticles (SPION) are biodegradable, biocompatible, and can be endocytosed into cells to render them responsive to magnetic fields. The synthesis process involves creating magnetite (Fe3O4) nanoparticles followed by high-speed emulsification to form a poly(lactic-co-glycolic acid) (PLGA) coating. The PLGA-magnetite SPIONs are approximately 120 nm in diameter including the approximately 10 nm diameter magnetite core. When placed in culture medium, SPIONs are naturally endocytosed by cells and stored as small clusters within cytoplasmic endosomes. These particles impart sufficient magnetic mass to the cells to allow for targeting within magnetic fields. Numerous cell sorting and targeting applications are enabled by rendering various cell types responsive to magnetic fields. SPIONs have a variety of other biomedical applications as well including use as a medical imaging contrast agent, targeted drug or gene delivery, diagnostic assays, and generation of local hyperthermia for tumor therapy or tissue soldering.
Targeted delivery and capture of cells to specific sites within the body is desirable for a variety of biomedical applications. Delivery of neural stem cells to the brain by MRI-guided focused ultrasound has been proposed as a possible treatment option for neurodegenerative disease, traumatic brain injury, and stroke1. Mesenchymal stem cells are being studied for their ability to deliver anti-cancer drugs to tumors due to their natural tumor-tropic properties2,3. Cardiac stem cells have been delivered to the heart as a possible treatment for myocardial infarction4,5. Vascular stents have been developed with CD34 antibodies to capture circulating progenitor cells6. While promising, these cell targeting approaches present drawbacks including lack of cell specificity, inconsistent cell retention, and off-target cell delivery.
The overall goal of the current method is to enable magnetically directed targeting of cells for a variety of cell delivery and sorting applications. Magnetic targeting allows for controlled delivery of specific cells to a specific target site with minimal off-target effects7. The magnetic fields can be generated by implanted or external devices to safely direct the movement of magnetically-labeled cells within the body8. Numerous research efforts have focused on magnetically directed targeting of stem cells to injured tissues such as the heart9-14, retina15, lung16, skin17, spinal cord18,19, bone20, liver21, and muscle22,23 in order to improve regeneration outcomes.
Magnetic targeting of cells has also been studied extensively as a means to endothelialize implantable cardiovascular devices. A uniform and complete endothelium provides a barrier between the device and circulating blood elements to mitigate thrombosis and inflammation. Endothelial cells can be delivered to the device either prior to implantation or via the vascular system following implantation. In both cases, magnetic fields are used to capture cells to the surface of the device and retain the cells when subjected to the shear stress generated by circulating blood. Magnetic vascular stents24-27 and vascular grafts28 have both been fabricated and tested for this purpose.
Magnetic cell targeting requires a strategy for labeling cells with magnetic carrier particles. These particles can be bound to the surface of cells via antibodies or ligand/receptor pairs or they can be endocytosed into the cells. Superparamagnetic iron oxide nanoparticles (SPION) are biodegradable, biocompatible, and readily endocytosed by a variety of cell types29. These particles effectively render a cell responsive to magnetic fields and are naturally degraded over time. SPIONs provide a straightforward and safe means of magnetically labeling cells in culture for a variety of magnetic targeting and sorting applications. A method for synthesizing SPIONs with a magnetite (Fe3O4) core and poly(lactic-co-glycolic acid) (PLGA) shell is provided. In addition, a method for labeling cells in culture with SPIONs is provided.
1. Synthesis of Magnetite Gel
2. Purification of Magnetite Gel
3. Coating of Magnetite Nanoparticles with PLGA Shell
4. Freeze-drying of SPIONs
5. Labeling of Cells with SPIONs
Magnetite nanoparticles are approximately 10 nm in diameter as a result of stirring an aqueous solution of iron(III) chloride and iron(II) chloride tetrahydrate at 50 °C and 1,000 rpm (Figure 1). These results demonstrate successful synthesis of magnetite nanoparticles. It is important to verify the size and shape of magnetite nanoparticles taken from a small sample of the batch when attempting the synthesis for the first time. Transmission electron microscopy (TEM) is the preferred method for visua...
As with any nanoparticle synthesis protocol, the purity of the reactant chemicals is critical for achieving high quality SPIONs that will have minimal cytotoxic effects. It is therefore important to purchase very pure reagents including oleic acid (≥99%), iron(II) chloride tetrahydrate (≥99.99%), iron(III) chloride (≥99.99%), ethyl acetate (HPLC grade, ≥99.9%), hexane (HPLC grade, ≥97.0%), ammonium hydroxide (≥99.99%), and sodium sulfate (≥99.0%). It is of particular importance t...
The authors declare that they have no competing financial interests.
The authors wish to acknowledge funding from the European Regional Development Fund – FNUSA-ICRC (no. CZ.1.05/ 1.1.00/ 02.0123), the American Heart Association Scientist Development Grant (AHA #06-35185N), and the National Institutes of Health (NIH #T32HL007111).
Name | Company | Catalog Number | Comments |
Ammonium Hydroxide solution, 28% NH3 in H2O, ≥99.99% trace metal basis | Sigma-Aldrich | 338818-100ML | Harmful reagent - wear personal protective equipment |
Dreschel bottle, 500 ml | Ace Glass | 5516-16 | |
Ethyl Acetate, CHROMASOLVR Plus, for HPLC, 99.9% | Sigma-Aldrich | 650528-1L | Harmful reagent - wear personal protective equipment & work in fume hood |
Ethyl alcohol | Sigma-Aldrich | E7023 | Harmful reagent - wear personal protective equipment |
Evaporating flask, 50 ml, 24/40 joint | Sigma-Aldrich | Z515558 | For use with rotoevaporator |
Filter paper, 3 cm dia, grade 1 | Fisher | 09-805P | For use with glass filter funnel |
Glass beakers, 1 L | Fisher | FB-101-1000 | For washing SPIONs |
Glass filter funnel, vacuum hose adapter, fits 24/40, 30 mL | Fisher | K954100-0344 | |
Glass vial caps | Fisher | 03-391-46 | For use with glass vials |
Glass vials, 2 ml | Fisher | 03-391-44 | For collecting magnetite gel & SPIONs |
Hexane, CHROMASOLVR, for HPLC, ≥97.0% (GC) | Sigma-Aldrich | 34859-1L | Harmful reagent - wear personal protective equipment & work in fume hood |
Hydrochloric acid | Sigma-Aldrich | H1758 | Harmful reagent - wear personal protective equipment & work in fume hood |
Iron(II) chloride tetrahydrate, ≥99.99% trace metals basis | Sigma-Aldrich | 380024-5G | Harmful reagent - wear personal protective equipment |
Iron(III) chloride anhydrous, powder, ≥99.99% trace metals basis | Sigma-Aldrich | 451649-1G | Harmful reagent - wear personal protective equipment |
Isomantle heater, 500 mL | Voight Global | EM0500/CEX1 | |
Laboratory mixer | Silverson | L5M-A | |
Lyophilizer | Labconco | 7670520 | |
Microspatulas | Fisher | 21-401-25A | For transfering magnetite gel |
NdFeB magnet, 1 in x 1 in x 1 in | Amazing Magnets | C1000H-M | Very strong magnet, handle with care |
Oleic acid, ≥99% (GC) | Sigma-Aldrich | O1008-5G | Store in freezer; Harmful reagent - wear personal protective equipment |
Overhead stirrer | IKA | 2572201 | |
Overhead stirrer clamp | IKA | 2664000 | For use with overhead stirrer |
Overhead stirrer H-stand | IKA | 1412000 | For use with overhead stirrer |
Phosphate buffered saline | Life Technologies | 10010-023 | |
Plastic beakers, 250 ml | Fisher | 02-591-28 | |
PLGA PURASORB PDLG (75/25 blend) | Purac | PDLG 7502 | PDLG 7502A may be used as well; Store in freezer |
Pluronic F-127 powder, BioReagent, suitable for cell culture | Sigma-Aldrich | P2443-250G | |
PTFE expandable blade paddle, 8 mm dia | SciQuip | SP4018 | |
PTFE vessel adapter, fits 24/40, 8 mm dia paddle | Monmouth Scientific | PTFE Vessel Adaptor A480 | For use with PTFE expandable blade paddle |
Recirculating chiller | Clarkson | 696613 | For use with rotoevaporator |
Reflux condenser, fits 24/40, 250 mm | Ace Glass | 5997-133 | |
Rotoevaporator | Clarkson | 216949 | |
Rubber septa, fits 24/40 | Ace Glass | 9096-56 | |
Separatory funnel with stopper, 250 ml | Fisher | 10-438E | |
Sodium sulfate ACS reagent, ≥99.0%, anhydrous, granular | Sigma-Aldrich | 239313-500G | |
Three neck round bottom flask, angled, 24/40 joints, 500 ml | Ace Glass | 6948-16 | |
Ultrasonic cleaner perforated pan | Fisher | 15-335-20A | For use with ultrasonic cleaner |
Ultrasonic cleaner, 2.8 L | Fisher | 15-335-20 | |
Vacuum controller | Clarkson | 216639 | For use with rotoevaporator (optional) |
Vacuum pump | Clarkson | 219959 | For use with rotoevaporator |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved